PANews reported on January 8 that Hyperbot data shows that "Strategy's counterparty" has closed all its short positions in BTC, ETH, SOL, XRP, kBONK, SUI, and FARTCOINPANews reported on January 8 that Hyperbot data shows that "Strategy's counterparty" has closed all its short positions in BTC, ETH, SOL, XRP, kBONK, SUI, and FARTCOIN

The "Strategy counterparty" has closed all short positions in multiple tokens including BTC and ETH, generating a profit of approximately $7.17 million in the past day.

2026/01/08 23:04

PANews reported on January 8 that Hyperbot data shows that "Strategy's counterparty" has closed all its short positions in BTC, ETH, SOL, XRP, kBONK, SUI, and FARTCOIN within the last 20 minutes, and its perpetual contract positions have been cleared. Its profit in one day was approximately $7.17 million, and its profit in the last month was approximately $10.01 million.

This address established its position last December, with a total account balance exceeding $31.78 million. After establishing the position, it continuously added to its short positions in major cryptocurrencies such as BTC and ETH. Its BTC short position once exceeded $120 million, making it the largest BTC short seller on the blockchain. This was comparable to the counterparty of Strategy, a publicly traded company that consistently bought BTC.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$90.725,91
$90.725,91$90.725,91
-0,49%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.